查找临床试验
已按「肺动脉高压」检索，对应国际通用词 pulmonary arterial hypertension
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:24，每 5 分钟自动同步China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization
China
年龄 14 Years – 不限
China-Japan Friendship Hospital
Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China
China
年龄 14 Years – 不限
China-Japan Friendship Hospital
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 不限
Insmed Incorporated
Preliminary Human Trials of F230 Tablets
China
年龄 18 Years – 45 Years
Beijing Continent Pharmaceutical Co, Ltd.
PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension
China
年龄 18 Years – 不限
First Affiliated Hospital of Fujian Medical University
A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
Taiwan
年龄 50 Years – 85 Years
National Defense Medical Center, Taiwan
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
China
年龄 3 Months – 85 Years
China National Center for Cardiovascular Diseases
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
China
年龄 18 Years – 65 Years
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension
China
年龄 18 Years – 75 Years
Guangdong Provincial People's Hospital
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
United States、Argentina、Austria、Brazil、Bulgaria 等 12 国
年龄 18 Years – 85 Years
Tenax Therapeutics, Inc.
Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury
China
年龄 18 Years – 75 Years
Second Affiliated Hospital, Zhejiang University, School of Medicine
Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)
Taiwan
年龄 18 Years – 85 Years
Foresee Pharmaceuticals Co., Ltd.